Skip to content
TrialScanner

NCT03983993

Niraparib and Panitumumab in Patients With Advanced or Metastatic Colorectal Cancer

Phase 2Active, not recruitingGSKCollaborator

Registry record

Lead sponsor
Emory University
Conditions
Advanced Microsatellite Stable Colorectal Carcinoma; Metastatic Microsatellite Stable Colorectal Carcinoma; Microsatellite Stable; RAS Wild Type; Stage IV Colorectal Cancer AJCC v8
Primary completion
May 17, 2023Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03983993 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03983993: Niraparib and Panitumumab in... | TrialScanner